U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07168265) titled 'The Effects of Androgen Replacement Therapy on Tear Osmolarity and Ocular Surface Parameters in Androgen Deficiency' on June 21.
Brief Summary: Objective: To evaluate tear osmolarity and ocular surface findings in men with androgen deficiency (AD) and assess changes after androgen replacement therapy (ART).
Design: A prospective interventional study. Participants and Methods Right eyes of 77 male participants were evaluated in this study. Serum total testosterone level were measured, and participants were categorized as AD group (testicular hypofunction, n=37, testosterone level 346 ng/dL). The parameters including Aging Male Symp...